2017   2016   2015   2014   2013   2012   2011   2010   2009   2008  

07. November 2009
Zedira presents Open tTGTM at MEDICA in November 2009
Document

02. November 2009
Meet Zedira at BIO-Europe in November 2009
Document

04. August 2009
Zedira co-authors patient information about the implication of transglutaminase in celiac disease (Article published in "DZG Aktuell" in August 2009; article in German)
Document

06. July 2009
Zedira develops drug against Celiac Disease (Article in Hessen-Biotech NEWS, July 2009; in German)
Document

02. April 2009
Transglutaminase Newsletter April 2009
Document

02. March 2009
Meet Zedira at 13th International Coeliac Disease Symposium 2009 in April 2009
Document

01. March 2009
Meet Zedira at 4th Annual Huntington's Disease Therapeutics Conference in Cannes 2009 in April 2009
Document

01. February 2009
Transglutaminase Newsletter February 2009 A complete range of antibodies available from Zedira!
Document

  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland